Control group:Wuji Baifeng Tablets Simulant

2 trials

Sponsors

Beijing Obstetrics and Gynecology Hospital Affiliated to Capital Medical University, Peking University Third Hospital

Conditions

Decreased ovarian reservepremature ovarian insufficiency

Phase 4

A randomized, double-blind, placebo-controlled, multicenter clinical trial of efficacy and safety of Wuji Baifeng Tablets in the treatment of decreased ovarian reserve (Qi and blood deficiency, liver and kidney deficiency syndrome)

RecruitingChiCTR2100054953

Peking University Third HospitalDecreased ovarian reserve

Start: 2021-12-29Updated: 2023-01-09

A randomized, double-blind, placebo-controlled, multicenter clinical trial of efficacy and safety of Wuji Baifeng Tablets in the treatment of premature ovarian insufficiency (Qi and blood deficiency, liver and kidney deficiency syndrome)

RecruitingChiCTR2100054952

Beijing Obstetrics and Gynecology Hospital Affiliated to Capital Medical Universitypremature ovarian insufficiency

Start: 2021-12-29Updated: 2023-01-09